06:03 EDT Autolus Therapeutics (AUTL) files $150M mixed securities shelf
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AUTL:
- Autolus Highlights ALL Opportunity and AUCATZYL CAR-T Platform
- Autolus Therapeutics Balances Growth Ambition With Rising Losses
- Autolus Therapeutics price target lowered to $10 from $12 at Mizuho
- Autolus: Transition-Year Execution and Aucatzyl Expansion Underscore Buy-Rated Long-Term Upside
- Midday Fly By: Carnival cuts forecast on fuel cost, Novartis to buy Excellergy